All pages
Jump to navigation
Jump to search
- VACTERL association
- VAC Therapy
- VAC regimen
- VAD
- VADT
- VAD regimen
- VALG staging
- VALG staging scheme
- VALI
- VALIANT
- VALIDD
- VALT
- VALUE
- VAMP1
- VAMP2
- VAMP3
- VAMP4
- VAMP5
- VANGL2
- VANQWISH
- VAP
- VAPA
- VAPB
- VAPEC-B regimen
- VAPRED Study
- VAQTA
- VARS
- VARS2
- VASH1
- VASIS
- VASP-02
- VASP-P
- VAT1
- VAT1L
- VATER association
- VATER syndrome
- VAV1
- VAV2
- VAV3
- VAX1
- VA Boston Healthcare System
- VA RNA
- VA lung cancer staging
- VA staging
- VBI
- VCAM-1
- VCAM1
- VCAN
- VCAP-AMP-VECP regimen
- VCAP regimen
- VCD regimen
- VCHSR
- VCJD
- VCPIP1
- VCSEL
- VCX
- VC dimension
- VC theory
- VD
- VDAC1
- VDAC2
- VDAC3
- VDJ recombination
- VDRL
- VDR regimen
- VDWS
- VE-cadherin
- VEA
- VEAPS
- VEB
- VEBs
- VECSEL
- VEE
- VEEV
- VEGAS-2
- VEGAS I
- VEGAS algorithm
- VEGF
- VEGF-165 Plasmid Gene Therapy in Patients with Refractory Angina Fails to Improve Outcomes in the Northern Trial
- VEGF-B
- VEGF-C
- VEGFB
- VEGFR-1
- VEGFR-2
- VEGFR1
- VEGFRs
- VEGF receptor
- VEGF receptors
- VEGF therapy
- VEGI
- VENUS
- VERBS
- VERDICT
- VERITAS
- VES
- VESIcare
- VEST
- VEXAS Syndrome
- VE (nerve agent)
- VF
- VFEND
- VG5Q
- VGF
- VG (nerve agent)
- VHAS
- VHD
- VHEFT-I
- VHEFT-II
- VHF
- VHFs
- VHL
- VHL gene
- VHL syndrome
- VHO
- VIAMI
- VICTOR
- VIMPAT
- VIM antisense RNA 1
- VINTAGE-MI
- VIP
- VIP-secreting tumor
- VIPAS39
- VIPR1
- VIPR2
- VIP regimen
- VIPoma
- VIPoma (patient information)
- VIPoma CT
- VIPoma MRI
- VIPoma case study one
- VIPoma causes
- VIPoma cost-effectiveness of therapy
- VIPoma diagnostic study of choice
- VIPoma differential diagnosis
- VIPoma echocardiography or ultrasound
- VIPoma electrocardiogram
- VIPoma epidemiology and demographics
- VIPoma future or investigational therapies
- VIPoma historical perspective
- VIPoma history and symptoms
- VIPoma interventions
- VIPoma laboratory findings
- VIPoma medical therapy
- VIPoma natural history
- VIPoma natural history, complications and prognosis
- VIPoma other diagnostic studies
- VIPoma other imaging findings
- VIPoma overview
- VIPoma pathophysiology
- VIPoma physical examination
- VIPoma primary prevention
- VIPoma risk factors
- VIPoma screening
- VIPoma secondary prevention
- VIPoma surgery
- VIPoma x ray
- VIPomas
- VISA
- VISA (gene)
- VISA / VRSA: Vancomycin-Intermediate/Resistant Staphylococcus aureus
- VISTA (protein)
- VITAL
- VIVA
- VKA
- VKH
- VKORC1
- VLA-4
- VLCADD
- VLCAD deficiency
- VLDL
- VLDLR-associated cerebellar hypoplasia
- VLDL Hyperlipidemia
- VLDL hyperlipidemia
- VLDL receptor
- VLPO
- VM-26
- VMA
- VMAC
- VMAT
- VMAT1
- VMAT2
- VMCM
- VMD2
- VMOS
- VM (nerve agent)
- VN1R1
- VN1R2
- VN1R3
- VN1R4
- VN1R5
- VNN1
- VNN2
- VNTR
- VO2 max
- VOCC
- VOC contamination of groundwater
- VOD
- VOR
- VP-16-213
- VPAP
- VPB
- VPBs
- VPC
- VPCs
- VPRBP
- VPREB1
- VPREB3
- VPS
- VPS11
- VPS13A
- VPS13B
- VPS13D
- VPS18
- VPS24
- VPS25
- VPS26A
- VPS26B
- VPS28
- VPS29
- VPS33B
- VPS35
- VPS36
- VPS37A
- VPS39
- VPS45
- VPS4A
- VPS4B
- VPS52
- VPS53
- VPS72
- VPSA
- VPS II
- VP Regimen
- VPg
- VQ OrthoCare
- VR-CHOP regimen
- VRBDA
- VRD regimen
- VRE
- VRK1
- VRK2
- VRSA
- VSD
- VSEPR
- VSEPR Theory
- VSIG2
- VSIG8
- VSNL1
- VSR
- VSX1
- VSX2
- VS ribozyme
- VT
- VTA1
- VTCN1
- VTD-PACE regimen
- VTE
- VTE and travel
- VTE economy class syndrome
- VTE in travelers
- VTE prevention
- VTE prevention resident survival guide
- VTE prophylaxis
- VTE prophylaxis resident survival guide
- VTE resident survival guide
- VTE risk calculator
- VTI1A
- VTI1B
- VTVF
- VT versus SVT
- VT vs SVT
- VTrain (Vocabulary Trainer)
- VVC
- VVS
- VWA2
- VWA5A
- VWD
- VWF
- VWF antigen
- VX (nerve agent)
- VX 950
- VZV
- VZV encephalitis
- V and P box gene transcriptions
- V box gene transcriptions
- V tach
- V wave
- VaZol
- Vacancy (chemistry)
- Vacant niche
- Vaccenic acid
- Vaccinated
- Vaccination
- Vaccination Act
- Vaccination policy
- Vaccination schedule
- Vaccinations
- Vaccine
- Vaccine-associated sarcoma
- Vaccine Adverse Event Reporting System
- Vaccine Safety Datalink
- Vaccine Use
- Vaccine and Infectious Disease Organization
- Vaccine associated polio
- Vaccine controversy
- Vaccine court
- Vaccine critic
- Vaccine derived paralytic polio
- Vaccine derived polio
- Vaccine efficacy
- Vaccine failure
- Vaccine injury
- Vaccine interference
- Vaccine mediated polio
- Vaccine mediated polio infection
- Vaccine related polio
- Vaccine related polio infection
- Vaccine schedule
- Vaccine trial
- Vaccines
- Vaccinia
- Vaccinia Immune Globulin
- Vaccinia virus
- Vaccinium vitis-idaea
- Vacinko syndrome
- Vacuolar H+ATPase
- Vacuole
- Vacuoles
- Vacuolization
- Vacuous truth
- Vacutainer
- Vacuum
- Vacuum UV
- Vacuum assisted closure
- Vacuum bell (medicine)
- Vacuum expectation value
- Vacuum extraction
- Vacuum fusion
- Vacuum massage
- Vacuum mattress
- Vacuum oven
- Vacuum splint
- Vagabond's disease
- Vagal
- Vagal disorder